Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Kimura; Tomio
Address:
Ube, JP
No. of patents:
13
Patents:












Patent Number Title Of Patent Date Issued
6063782 Pyrrolopyridazine derivatives May 16, 2000
Pyrrolopyridazine derivatives having the general formula. ##STR1## In the above formula, R.sup.1 represents a C.sub.2 -C.sub.6 alkenyl-group, a halogeno-C.sub.2 -C.sub.6 -alkenyl group, a C.sub.6 -C.sub.10 aryl-C.sub.2 -C.sub.6 -alkenyl group, a C.sub.2 -C.sub.6 alkynyl group, a
5688791 Aryl group-or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv ag November 18, 1997
Disclosed are an aryl group- or heterocyclic group-substituted aminoquinolone compound represented by the formula (Ia), (Ib) or (Ic): ##STR1## wherein each of the substitutents are defined in the specification, or a salt of the compound, and an AIDS curing agent containing the same a
5519016 Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV a May 21, 1996
Disclosed are an aryl group- or heterocyclic group-substituted aminoquinolone compound represented by the formula (Ia), (Ib) or (Ic): ##STR1## wherein each of the substitutents are defined in the specification, or a salt of the compound, and an AIDS curing agent containing the same a
5496951 4-oxoquinoline-3-carboxylic acid derivatives their preparation and their use March 5, 1996
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy: R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
5436367 Intermediates for certain 4-oxoquinoline-3-carboxylic acid derivatives July 25, 1995
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
5436242 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood plat July 25, 1995
Compounds of formula (I): ##STR1## wherein R.sup.1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R.su
5348961 4-oxoquinoline-3-carboxylic acid derivatives and their use September 20, 1994
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
5288726 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and February 22, 1994
Compounds of formula (I): ##STR1## wherein: R.sup.1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R.s
5073556 4-oxoquinoline-3-carboxylic acid derivatives and their use December 17, 1991
Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial
4997943 Quinoline-3-carboxylic acid derivatives March 5, 1991
Compounds of formula (I): ##STR1## (in which R.sup.1 is alkoxy, R is alkyl, haloalkyl, alkylamino, cycloalkyl or optionally substituted phenyl, X is chlorine or fluorine and Y is selected from certain specific heterocycles) have excellent antibacterial activity. They may be prepa
4749704 Cyclopenta[d]pyrimidine derivatives and use as antidepressants June 7, 1988
Compounds of formula (I): ##STR1## (wherein R.sup.1 and R.sup.2 are hydroxy, alkoxy, aryloxy or acyloxy or R.sup.2 is hydrogen, R.sup.3 is hydrogen or alkyl and R.sup.4 and R.sup.5 are hydrogen or various organic substituents) have valuable antidepressant activity and may be used
4497957 Process for preparing optically active tryptophans February 5, 1985
Biochemical optical resolution of DL-tryptophans in which DL-tryptophan amides are interacted with the culture products, or their treated products, of a microorganism capable of producing amidase is described. L-Tryptophan amides in racemic DL-tryptophan amides are asymmetrically hyd
4443548 Process for preparing L-.alpha.-methylphenyl alanines April 17, 1984
Biochemical optical resolution of DL-.alpha.-methylphenyl alanines in which DL-.alpha.-methylphenyl alanine amides are interacted with the culture products, or their treated products, of a microorganism capable of producing amidase is described. L-.alpha.-methylphenyl alanines having the










 
 
  Recently Added Patents
Laser protection polymeric materials
Image forming apparatus detecting color patterns and generating interleaf images at predetermined position
Method for execution upon processing of at least one histological sample
Sensor chip, sensor cartridge, and analysis apparatus
Scalable security services for multicast in a router having integrated zone-based firewall
Quantifying the risks of applications for mobile devices
Focus detection device and imaging apparatus having the same
  Randomly Featured Patents
Float activated gauge
Optical disk device including buffer mechanism for buffering elastic deformation of the optical pickup side of a disk motor plate
Finished-stair-tread adapter for a modular railing system
Livestock drinking device
Coating apparatus
Dual clutch transmission having a synchronizer actuation interlock circuit
Side pocket mandrel
Kits for DNA sequencing by stepwise ligation and cleavage
Rotor spinning apparatus with spinning box dirt separator
System for producing combination circuit to satisfy prescribed delay time by deleting selected path gate and allowing to perform the permissible function for initial circuit